Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
LY2886721: BACE1 Inhibition in AD Research
2026-08-28
LY2886721 is an oral BACE inhibitor for mechanistic Alzheimer’s disease treatment research. Reported nanomolar activity, amyloid beta reduction in cellular and mouse models, and biomarker modulation support its use for studying BACE1 enzyme inhibition rather than as evidence of clinical efficacy.
-
Pexmetinib (ARRY-614): A State-Aware Strategy
2026-08-27
Pexmetinib (ARRY-614) offers translational researchers a dual-pathway framework for connecting p38 MAPK signaling, Tie2 biology, cytokine output, and bone marrow disease models. This thought-leadership analysis combines product evidence with recent structural insights into kinase dephosphorylation to propose more discriminating assay designs, validation workflows, and translational decision points.
-
Ganetespib (STA-9090): Hsp90 Research Guide
2026-08-27
Ganetespib, also called STA-9090, is a triazolone-containing small-molecule Hsp90 inhibitor for experimental cancer research. Product information links competitive N-terminal ATP-pocket binding with client-protein degradation and reports nanomolar cellular activity plus tumor regression in a mouse xenograft model.
-
Psoralen-Induced Cholestasis via ERK1/2
2026-08-26
A 2024 Chemical Research in Toxicology study shows that psoralen and isopsoralen, estrogen-like constituents of Psoraleae Fructus, induce cholestatic liver injury in zebrafish larvae through altered bile-acid regulation and ERK1/2 activation. Pharmacological rescue with an ERK1/2 antagonist and exemestane links estrogenic signaling to the injury phenotype and provides a mechanistic framework for studying phytoestrogen-associated cholestasis.
-
Alfuzosin HCl Research Workflow Guide
2026-08-26
Build reproducible Alfuzosin HCl workflows for receptor pharmacology, smooth-muscle assays, dissolution testing, and combination-product analysis. A validated green spectrophotometric study provides a practical route for resolving Alfuzosin HCl and tadalafil when their absorbance spectra overlap.
-
Isoproterenol and Human Pacemaker Assembloids
2026-08-25
A translational framework for using Isoproterenol sulfate dihydrate to interrogate beta-adrenergic control, pacemaker maturation, and neuro-cardiac function in human SAN-plexus assembloids.
-
XAV-939 Workflows for Wnt and Bone Research
2026-08-25
XAV-939, also known as NVP-XAV939, combines nanomolar tankyrase inhibition with practical applications in Wnt pathway, cancer, fibrosis, and osteoblast research. This guide translates its axin-stabilizing mechanism into reproducible cell workflows and shows how to connect β-catenin, glycolysis, O-GlcNAcylation, and mineralization readouts.
-
Intestinal TM6SF2 and the Gut–Liver Axis in MASH
2026-08-24
This study shows that intestinal epithelial TM6SF2 protects against MASH by maintaining barrier integrity and limiting microbiota- and lipid-mediated gut–liver signaling. Conditional mouse genetics, germ-free fecal transplantation, co-housing, molecular profiling, and LPA-receptor intervention together identify a mechanistic pathway linking intestinal TM6SF2 deficiency to hepatic lipid accumulation and inflammation.
-
5-EdU Workflows for S Phase DNA Synthesis
2026-08-24
Turn a short 5-EdU pulse into a sensitive readout of newly synthesized DNA for stem-cell, tumor, and regeneration models. This workflow emphasizes assay design, quantitative controls, and troubleshooting so click-based detection remains biologically interpretable.
-
Tetracycline as a Translational Research Bridge
2026-08-23
Tetracycline is more than a broad-spectrum polyketide antibiotic: it is a disciplined workflow tool for selection, ribosomal function research, and model quality control. This article connects its established antibacterial mechanism with the QRICH1–ER stress–HMGB1 axis reported in HBV-associated hepatic fibrosis, while clearly separating evidence from strategic extrapolation.
-
Isoprenaline Hydrochloride in Heart–Brain Assays
2026-08-22
Isoprenaline Hydrochloride is more than a cardiac stimulant: it can encode sympathetic cardiac stress for mechanistic heart–brain experiments. This guide explains how isoproterenol exposure, causal controls, and multimodal readouts can distinguish cardiac drivers from downstream neural and behavioral effects.
-
GPNMB Model Predicts ESCC Immunotherapy Response
2026-08-22
The reference study identifies circulating soluble GPNMB as a mechanistic biomarker of CD8+ T-cell exhaustion and resistance to PD-1 blockade in esophageal squamous cell carcinoma. Its multimodal model combines plasma GPNMB, CAF-Epi niche features, and clinicopathological variables to improve response and survival prediction across retrospective and prospective cohorts.
-
ASB3-MAVS Ubiquitination in Antiviral Immunity
2026-08-21
The 2024 reference study identifies ASB3 as an inducible negative regulator of antiviral innate immunity that targets MAVS for K48-linked ubiquitination and proteasomal degradation. Its genetic, infection, biochemical, and animal experiments connect ASB3 activity to reduced TBK1–IRF3 signaling, impaired type I interferon production, and increased susceptibility to influenza A virus.
-
BOP Reagent and Translational Prodrug Design
2026-08-20
BOP reagent is more than a peptide coupling reagent: its controlled carboxyl activation can support modular synthesis strategies that matter for translational prodrug research. This article connects peptide-bond chemistry with the carrier-free, ROS-responsive triterpene platform reported for oral squamous cell carcinoma, while separating established chemistry from preclinical opportunity.
-
EdU Imaging Kits (488) for Stem Cell Proliferation
2026-08-20
EdU Imaging Kits (488) translate DNA replication into a clear fluorescence signal without the harsh denaturation required by BrdU assays. The workflow is especially useful for comparing disease-associated stem-cell proliferation, preserving morphology and antigen-binding sites, and combining microscopy with flow cytometry.